Children’s Memorial Hermann Hospital (UTHealth) and Cord Blood Registry are enrolling individuals for the first FDA-regulated safety study to investigate the use of a child’s own umbilical cord blood stem cells for traumatic brain injury in children. For more information on this clinical trial, sign up here.
How does the study work?
The innovative study will span a six-month, one year and two-year time period and follow 10 children, ages 18 months to 17 years, who have umbilical cord blood banked with Cord Blood Registry and have suffered moderate to severe traumatic brain injury (TBI). The study is not designed for acute care and will only enroll participants within 6-18 months of their injury.
The study will include 40 children age 1-12 whose parents have stored cord blood with Cord Blood Registry. Study participants must have been unable to sit independently by 12 months or unable to walk by 18 months and must be seizure-free or have seizures that are adequately controlled.
To ensure consistency in cord blood stem cell processing, storage and release for infusion, the Cord Blood Registry is the only family stem cell bank participating in the study.